WO2004100861A3 - Pharmaceutical composition comprising lectin - Google Patents

Pharmaceutical composition comprising lectin Download PDF

Info

Publication number
WO2004100861A3
WO2004100861A3 PCT/BR2004/000070 BR2004000070W WO2004100861A3 WO 2004100861 A3 WO2004100861 A3 WO 2004100861A3 BR 2004000070 W BR2004000070 W BR 2004000070W WO 2004100861 A3 WO2004100861 A3 WO 2004100861A3
Authority
WO
WIPO (PCT)
Prior art keywords
lectin
pharmaceutical composition
heal
plant
prevent
Prior art date
Application number
PCT/BR2004/000070
Other languages
French (fr)
Other versions
WO2004100861A2 (en
Inventor
Da Silva Luis Lamberti Pinto
Castelo Ademilson Panunto
Souza Goldman Maria Helena De
Antunes Barreira Maria C Roque
Oliveira Ricardo Santos De
Baruffi Marcelo Dias
De Molfetta Machado Jea Blanco
Original Assignee
Fundacao De Amparo A Pesquisa
Univ Sao Paulo
Da Silva Luis Lamberti Pinto
Castelo Ademilson Panunto
Souza Goldman Maria Helena De
Antunes Barreira Maria C Roque
Oliveira Ricardo Santos De
Baruffi Marcelo Dias
De Molfetta Machado Jea Blanco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao De Amparo A Pesquisa, Univ Sao Paulo, Da Silva Luis Lamberti Pinto, Castelo Ademilson Panunto, Souza Goldman Maria Helena De, Antunes Barreira Maria C Roque, Oliveira Ricardo Santos De, Baruffi Marcelo Dias, De Molfetta Machado Jea Blanco filed Critical Fundacao De Amparo A Pesquisa
Priority to EP04733749A priority Critical patent/EP1635891A2/en
Priority to JP2006529469A priority patent/JP2007528869A/en
Publication of WO2004100861A2 publication Critical patent/WO2004100861A2/en
Publication of WO2004100861A3 publication Critical patent/WO2004100861A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42Lectins, e.g. concanavalin, phytohaemagglutinin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention deals with a pharmaceutical composition comprising lectin KM+ to prevent and heal epithelial wounds. The invention also comprises the use of lectin KM+, obtained from the plant Artocarpus integrifolia or the use of recombinant lectin to prepare medicaments.
PCT/BR2004/000070 2003-05-19 2004-05-19 Pharmaceutical composition comprising lectin WO2004100861A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP04733749A EP1635891A2 (en) 2003-05-19 2004-05-19 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition, insecticide use of lectin km+ to treat cicatrizations, use of lectin km+ to prepare immunomodulating medicament
JP2006529469A JP2007528869A (en) 2003-05-19 2004-05-19 Pharmaceutical composition for epithelial wound prevention and treatment, immunoregulatory pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition, use of insecticide of lectin KM + in the treatment of scarring, use of lectin KM + in preparation of immunoregulatory drug , Use of lectin KM + in formulating antibacterial drugs, use of lectin KM + in formulating antiviral drugs, use of lectin KM + in formulating antifungal drugs, use of lectin KM + in formulating antiparasitic drugs, expression methods, DNA vectors, recombinant organisms , Nucleotide sequences, antibodies, proteins and extranuclear genes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRC10301547-5A BR0301547C1 (en) 2003-05-19 2003-05-19 pharmaceutical composition for treating fungal pathology comprising km + lectin, pharmaceutical composition for preventing fungal pathology comprising km + lectin, use of km + lectin for preparing medicine for treating fungal pathology, use of km + lectin for preparing medicine for preventing fungal pathology
BRPI0301547-5 2003-05-19

Publications (2)

Publication Number Publication Date
WO2004100861A2 WO2004100861A2 (en) 2004-11-25
WO2004100861A3 true WO2004100861A3 (en) 2006-12-07

Family

ID=37744501

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2004/000070 WO2004100861A2 (en) 2003-05-19 2004-05-19 Pharmaceutical composition comprising lectin

Country Status (5)

Country Link
EP (1) EP1635891A2 (en)
JP (1) JP2007528869A (en)
AR (1) AR044389A1 (en)
BR (1) BR0301547C1 (en)
WO (1) WO2004100861A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2914858B1 (en) * 2007-04-13 2012-09-21 Lucas Meyer Cosmetics COSMETIC COMPOSITION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020001600A1 (en) * 1995-05-30 2002-01-03 Michael J. Oldham Method of using lectins for prevention and treatment of skin diseases and disorders

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, vol. 29, no. 8, pages 977 - 985 *
DATABASE MEDLINE [online] MORAES SM ET AL: "Purification, physicochemical characterization and biological properties of a lectin from Erythrina velutina forma aurantiaca seeds", XP003004899, Database accession no. NLM9181078 *
DATABASE MEDLINE [online] SANTOS- DE OLIVIERA R ET AL: "A neutrophil migration inducing lectin from Artocarpus integrifolia", XP003004898, Database accession no. NLM8046246 *
JOURNAL OF IMMUNOLOGY, vol. 153, no. 4, 1994, pages 1798 - 1807 *
ROSA J.C. ET AL.: "KM+, a mannose-binding lectin from Artocarpus integrifolia: Amino acid sequence, predicted tertiary structure, carbohydrate recognition, and analysis of the beta-prism fold", PROTEIN SCIENCE, vol. 8, 1999, pages 13 - 24, XP003005454 *

Also Published As

Publication number Publication date
EP1635891A2 (en) 2006-03-22
AR044389A1 (en) 2005-09-07
BR0301547A (en) 2005-03-22
BR0301547C1 (en) 2007-02-21
WO2004100861A2 (en) 2004-11-25
JP2007528869A (en) 2007-10-18

Similar Documents

Publication Publication Date Title
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
CA2528075A1 (en) Low temperature liquid polythioether polymers
EP2269631A3 (en) Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
WO2007010034A3 (en) Ampholytic copolymer, production thereof, and use of the same
BRPI0512326A (en) compositions comprising amphotericin b, methods and systems
WO2006037981A8 (en) Inhibition of tumour cell migration
WO2006138735A3 (en) Gel compositions for topical administration
WO2007022784A3 (en) Liquid factor vii composition
EP1978068A3 (en) Adhesive Structures for Attachment to Skin
BR0308486A (en) Topical composition comprising a cyclofrutane, a vehicle and a drug
MX2009009045A (en) Fragrance dispenser.
WO2004041257A3 (en) Novel nutraceutical compositions comprising epigallocatechin gallate
WO2003099192A8 (en) Bis-aromatic alkanols
WO2007133944A3 (en) Topical administration of acyclovir
WO2007068252A3 (en) Bovine osteopontin formulations for the improvement of the wound healing process
WO2008078109A3 (en) Medicament
WO2004100861A3 (en) Pharmaceutical composition comprising lectin
WO2006055663A3 (en) The use of novel antibacterial compounds
MXPA03006648A (en) Anti-thrombotic compounds, production and use thereof as medicaments.
WO2004065320A3 (en) Age-stable composition having a polysaccharide
WO2004078142A3 (en) Compositions and methods for preventing and treating endotoxin-related diseases and conditions
WO2001046128A3 (en) Tryptase inhibitors
WO2004026319A3 (en) Pharmaceutical compositions increasing camp useful for the treatment of cancers
WO2006023707A3 (en) 2-aminothiophenecarboxamides useful as cancer chemotherapeutic agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006529469

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004733749

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004733749

Country of ref document: EP